Navigating climate-focused AI funding offers a unique milestone for turning research concepts into transformative tools. CEO Aaron Schacht describes how BiomEdit’s Bezos-funded “digital twin” work aims to model genetics, feed and microbiome to predict performance and methane reduction, creating a platform that could serve both producers and future commercial partners.

For emerging biotech companies, the right partnerships are pivotal to growth. Dr. Tony Sasse, Founder & Managing Director of Snoretox, shares how his team identified investors and collaborators who believed in their mission and understood their market. Learn how strategic alignment is helping Snoretox progress toward licensing and manufacturing deals that will bring their innovation to market.

Before launching into development, Dr Erwin Blomsma took a research-first approach, surveying veterinarians, analysing clinic data, and identifying a major gap in canine cancer care. He shares how this market insight built investor conviction and informed a therapy ultimately creating a pathway to longer, healthier lives for dogs with bladder cancer.